News

COMPANY NEWS

05 Dec 2024 · 1 min read

Lumos Diagnostics receives CPT PLA procedure code approval for FebriDx™ in the US

Lumos has today announced that it has received approval from the Centers for Medicare and Medicaid Services...

Read article

COMPANY NEWS

21 Nov 2024 · 1 min read

Nine News Coverage

Lumos' FebriDx® was featured on Channel 9 News during its prime time 6pm national bulletin last night...

Read article

COMPANY NEWS

08 Oct 2024 · 1 min read

Lumos Successfully Completes Retail Entitlement Offer

Lumos Diagnostics has announced that it has successfully completed the retail component of its Entitlement Offer...

Read article

COMPANY NEWS

03 Oct 2024 · 1 min read

Lumos and BARDA to Partner to Support FebriDx® CLIA Waiver Study and Application

Lumos has been awarded US$2,984,571 from the Biomedical Advanced Research and Development Authority (BARDA)...

Read article

COMPANY NEWS

25 Sep 2024 · 1 min read

Lumos Awarded National Contract with MediGroup for FebriDx®

Lumos Diagnostics has been awarded placement of their novel POC test, FebriDx®...

Read article

COMPANY NEWS

16 Sep 2024 · 1 min read

Lumos Appoints Thermo Fisher Scientific as US Distributor for FebriDx®

Lumos Diagnostics has signed an agreement with Fisher Healthcare, a part of Thermo Fisher Scientific...

Read article

COMPANY NEWS

06 Sep 2024 · 1 min read

Lumos Successfully Completes Institutional Component of Entitlement Offer

Lumos Diagnostics has today announced that it has successfully completed the institutional component...

Read article

COMPANY NEWS

27 Aug 2024 · 2 min read

FY24 Annual Report

Lumos has today published its Annual Report for FY24...

Read article

COMPANY NEWS

01 Aug 2024 · 1 min read

Video | Q4 FY24 Investor webinar

Lumos CEO, Doug Ward, Chief Financial Officer, Barrie Lambert, and Senior VP Commercial Operations, Paul Kase...

Read article

COMPANY NEWS

31 Jul 2024 · 2 min read

Lumos Diagnostics Quarterly Activity Statement and Cash Flow Report period ended 30 June 2024

Lumos Diagnostics has released its Quarterly Report & 4C for the period ending 30 June 2024.

Read article

COMPANY NEWS

15 Jul 2024 · 1 min read

Stockhead | Air supply: The ASX medtechs tackling respiratory illnesses

Lumos Diagnostics has been included in a Stockhead article spotlighting medtech companies addressing respiratory illness...

Read article

COMPANY NEWS

12 Jul 2024 · 1 min read

Video | Q&A with Paul Kase, SVP, Commercial Operations

In this Q&A with Paul Kase, Lumos’ SVP, Commercial Operations, Paul outlines how Lumos is working in partnership with Henry Schein...

Read article